These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23975428)

  • 21. MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2.
    Xing F; Song Z; He Y
    Biol Res; 2018 Nov; 51(1):50. PubMed ID: 30474570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.
    Chang HY; Ye SP; Pan SL; Kuo TT; Liu BC; Chen YL; Huang TC
    Theranostics; 2017; 7(16):3889-3900. PubMed ID: 29109785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression.
    Zhao D; Ma J; Shi J; Cheng L; Li F; Jiang X; Jiang H
    Oncol Rep; 2013 Jul; 30(1):304-12. PubMed ID: 23674108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
    Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
    Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raf kinase inhibitory protein role in the molecular subtyping of breast cancer.
    Al-Mulla F; Marafie M; Zea Tan T; Paul Thiery J
    J Cell Biochem; 2014 Mar; 115(3):488-97. PubMed ID: 24123286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
    Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
    Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
    Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer.
    Wottrich S; Kaufhold S; Chrysos E; Zoras O; Baritaki S; Bonavida B
    Drug Resist Updat; 2017 Jan; 30():28-38. PubMed ID: 28363333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-106a-5p Suppresses the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting HMGA2.
    He QY; Wang GC; Zhang H; Tong DK; Ding C; Liu K; Ji F; Zhu X; Yang S
    DNA Cell Biol; 2016 Sep; 35(9):506-20. PubMed ID: 27383537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of novel metastasis suppressor signaling pathways for breast cancer.
    Minn AJ; Bevilacqua E; Yun J; Rosner MR
    Cell Cycle; 2012 Jul; 11(13):2452-7. PubMed ID: 22659842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer.
    Wend P; Runke S; Wend K; Anchondo B; Yesayan M; Jardon M; Hardie N; Loddenkemper C; Ulasov I; Lesniak MS; Wolsky R; Bentolila LA; Grant SG; Elashoff D; Lehr S; Latimer JJ; Bose S; Sattar H; Krum SA; Miranda-Carboni GA
    EMBO Mol Med; 2013 Feb; 5(2):264-79. PubMed ID: 23307470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circular RNA 100146 Promotes Colorectal Cancer Progression by the MicroRNA 149/HMGA2 Axis.
    Liu K; Mou Y; Shi X; Liu T; Chen Z; Zuo X
    Mol Cell Biol; 2021 Jan; 41(2):. PubMed ID: 33257506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RKIp inhibits the migration and invasion of human prostate cancer PC-3M cells through regulation of extracellular matrix.
    Xinzhou H; Ning Y; Ou W; Xiaodan L; Fumin Y; Huitu L; Wei Z
    Mol Biol (Mosk); 2011; 45(6):1004-11. PubMed ID: 22295570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raf kinase inhibitor protein mediated signaling inhibits invasion and metastasis of hepatocellular carcinoma.
    Wu X; Yang Y; Xu Z; Li J; Yang B; Feng N; Zhang Y; Wang S
    Biochim Biophys Acta; 2016 Feb; 1860(2):384-91. PubMed ID: 26116914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.
    He QY; Yi HM; Yi H; Xiao T; Qu JQ; Yuan L; Zhu JF; Li JY; Wang YY; Li LN; Feng J; Lu SS; Xiao ZQ
    Oncotarget; 2015 Jun; 6(18):16422-36. PubMed ID: 25915430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Forkhead Box F1 promotes breast cancer cell migration by upregulating lysyl oxidase and suppressing Smad2/3 signaling.
    Nilsson G; Kannius-Janson M
    BMC Cancer; 2016 Feb; 16():142. PubMed ID: 26908052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
    Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
    J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor suppressor RKIP inhibits prostate cancer cell metastasis and sensitizes prostate cancer cells to docetaxel treatment.
    Zhu CX; Li WZ; Guo YL; Chen L; Li GH; Yu JJ; Shu B; Peng S
    Neoplasma; 2018; 65(2):228-233. PubMed ID: 29534584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.